Cardinal Health will pay $13M to settle kickback allegations

Pharmaceutical distributor Cardinal Health has agreed to pay more than $13 million to settle allegations it gave doctors kickbacks to purchase medicines paid for by federal health programs.

The Department of Justice said Monday that the Ohio-based drug distributor violated the Anti-Kickback Statute by offering to pay physician practices upfront discounts to buy certain pharmaceuticals paid for by Medicare.

Under the rule, distributors are permitted to offer commercially available discounts to customers who meet certain conditions, but Cardinal Health failed to meet those requirements.

“Cardinal Health thought it hit upon a surefire moneymaker by paying kickbacks to doctors, which cost health benefit programs millions of dollars in potentially fraudulent claims,” Joseph R. Bonavolonta, special agent in charge of the Federal Bureau of Investigation, Boston Division, said in a statement. “Anyone involved in, or entertaining, similar activity should know that healthcare fraud is a priority for the FBI, and we will pursue anyone trying to profit from this country’s vital healthcare system.”

Cardinal Health did own up to certain facts as part of the $13.13 million settlement but did not admit to any liability, according to Reuters.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”